Marksans Pharma Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Marksans Pharma Limited Press Release regarding unaudited financial results for the quarter and half year ended September 30, 2025".
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted a press release to the stock exchange dated November 13, 2025, sharing its unaudited financial results for the quarter and half year ending September 30, 2025. The filing itself does not include the detailed numbers, only notifying the exchange that the press release has been issued. Investors will need to refer to the actual press release or the full results document for revenue, profit, and other key financial figures. This is a routine quarterly disclosure under listing requirements.
The press release typically triggers a re-rating based on whether the numbers beat or miss market expectations. Until the actual financials are reviewed, the immediate stock impact is likely limited to trading on sentiment and analyst expectations for the quarter.